Press Releases
All Releases
Jun 03, 2019
AngioDynamics Completes Sale of NAMIC® Fluid Management Portfolio to Medline Industries, Inc.
May 28, 2019
AngioDynamics to Ring NASDAQ Closing Bell to Celebrate the 15th Anniversary of its Listing on the Exchange
May 22, 2019
AngioDynamics Receives FDA Approval to Initiate Pilot Study for the Use of NanoKnife® to Treat Prostate Cancer
May 13, 2019
AngioDynamics Announces First Patient Enrolled in NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer
Apr 17, 2019
AngioDynamics Announces Agreement to Sell NAMIC® Fluid Management Business to Medline Industries, Inc. for $167.5 Million
Apr 17, 2019
AngioDynamics’ DIRECT Clinical Study Receives Institutional Review Board Approval for the Treatment of Stage III Pancreatic Cancer
Apr 02, 2019
AngioDynamics Reports Fiscal 2019 Third Quarter Financial Results
Apr 01, 2019
AngioDynamics to Present at the Needham Healthcare Conference
Apr 01, 2019
AngioDynamics Receives FDA Approval to Initiate NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer
Mar 28, 2019
CORRECTING and REPLACING OARtrac® Radiation Dose Monitoring System Receives Expanded FDA Clearance for Electron Radiation Therapy
Mar 12, 2019
AngioDynamics to Report Fiscal 2019 Third Quarter Financial Results on April 2, 2019
Mar 08, 2019
AngioDynamics Wins Patent Infringement Dispute With Bard
Feb 26, 2019
AngioDynamics to Present at the Barclays Global Healthcare Conference
Jan 04, 2019
AngioDynamics Reports Fiscal 2019 Second Quarter Financial Results
Dec 20, 2018
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
Dec 10, 2018
AngioDynamics to Report Fiscal 2019 Second Quarter Financial Results on January 4, 2019
Sep 27, 2018
AngioDynamics Reports Fiscal 2019 First Quarter Financial Results
Sep 19, 2018
AngioDynamics to Present at the Cantor Global Healthcare Conference
Sep 13, 2018
AngioDynamics to Report Fiscal 2019 First Quarter Financial Results on September 27, 2018
Sep 13, 2018
AngioDynamics to Acquire RadiaDyne and its Revolutionary OARtrac® Radiation Dose Monitoring Platform to Further Expand Oncology Portfolio
Displaying 81 - 100 of 719